Abstract
Breast cancer is the most common cancer and the second leading cause of cancer deaths among women in the United States (1). Although cancer mortality has declined due to improvements in early detection and treatment, and the 5-year overall survival is high (89%), vulnerable patient groups including racial and ethnic minorities continue to experience disproportionate burdens of mortality from breast cancer (1). A growing body of literature supports longstanding concerns that racial, ethnic, geographic, and socioeconomic factors influence access and quality at all phases of oncologic care, from screening to treatment to surveillance to end-of-life care (2).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.